<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">T-cell heterogeneity in muscle lesions of inclusion body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Anke</forename><surname>Bender</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Luder</forename><surname>Behrens</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="laboratory">Neuromuscular Research Laboratory</orgName>
								<orgName type="institution">Mayo Clinic and Mayo Foundation</orgName>
								<address>
									<postCode>55905</postCode>
									<settlement>Rochester</settlement>
									<region>MN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Reinhard</forename><surname>Hohlfeld</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">UniÕersity of Munich</orgName>
								<address>
									<addrLine>Klinikum Grosshadern</addrLine>
									<postCode>D-81366</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Neuroimmunology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute</orgName>
								<address>
									<postCode>D-82152</postCode>
									<settlement>Martinsried</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">T-cell heterogeneity in muscle lesions of inclusion body myositis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">5851D23477A70AE1F1464468A3112402</idno>
					<note type="submission">Received 25 August 1997; accepted 5 November 1997</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Inflammatory muscle disease</term>
					<term>Autoimmunity</term>
					<term>TCR</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>In the muscle lesions of inclusion body myositis IBM , two populations of T cells can morphologically be distinguished, T cells that invade muscle fibers and T cells that remain in interstitial areas. Using combined immunohistochemistry and RT-PCR, we analysed the TCR expressed by these distinct T cell populations. In three of eight IBM muscle specimens, the autoinvasive T cells were stained with one of the available mAbs: anti-Vb 5.3 in patient 1, anti-Vb 5.2 in patient 2, and anti-Vb 3 in patient 3. The corresponding TCR Vb mRNAs were amplified by RT-PCR and the PCR products were cloned and sequenced. In all three specimens, the TCRs expressed by the autoinvasive T cells were clonally restricted. Furthermore, in patient 1 two different mAbs labelled two distinct populations of T cells: an autoaggressive population of CD8 q Vb 5.3 q cells that invaded muscle fibers and a noninvasive interstitial population of CD8 y Vb 5.1 q cells. TCR sequence analysis revealed that the noninvasive Vb 5.1 q T cells were clonally diverse, whereas the autoinvasive Vb 5.3 q T cells were clonally restricted. q 1998 Elsevier Science B.V.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ž</head><p>. Inclusion body myositis IBM accounts for about 30% of the idiopathic inflammatory myopathies in adults and is the most frequent inflammatory myopathy after 50 yr of age. In contrast to the other idiopathic inflammatory my-Ž . Ž . opathies, polymyositis PM and dermatomyositis DM , IBM tends to be refractory to immunotherapy. Histologically, CD8 q cytotoxic T cells invade muscle fibers in Ž . both IBM and PM <ref type="bibr" target="#b8">Engel and Arahata, 1984 .</ref> Immunoelectron microscopy reveals that CD8 q T cells accompanied by a lesser number of macrophages traverse the basal lamina of the muscle fiber, focally replace, displace or compress the fiber, and ultimately replace entire segments Ž . of muscle fiber <ref type="bibr" target="#b1">Arahata and Engel, 1986</ref> . The autoinvasive T cells contain cytotoxic granules, which are oriented Ž . towards the target muscle fiber <ref type="bibr">Goebels et al., 1996 . All</ref> Abbreviations: DM: dermatomyositis; IBM: inclusion body myositis; PM: polymyositis; TCR: T-cell receptor</p><p>) Corresponding author. Tel.: q49 89 70954780; fax.: q49 89 70954782; e-mail: hohlfeld@neuro.mpg.de invaded and some noninvaded fibers express increased Ž amounts of HLA class <ref type="bibr">I Hohlfeld and Engel, 1994;</ref><ref type="bibr" target="#b9">Engel . et al., 1994</ref> . Taken together, these observations point to an HLA-class-I-restricted immune response mediated by cytotoxic CD8 q T cells and directed against yet unknown Ž . antigen s on the surface of the invaded muscle fibers. Because to date all attempts to demonstrate viral proteins or genes in IBM muscle have failed, the CD8 q autoinvasive T cells likely recognize one or several peptides de-Ž . rived from self-antigen s expressed in muscle fibers.</p><p>The unique morphology of the typical IBM and PM lesion allows identification of T cells that contact and Ž . invade nonnecrotic muscle fibers autoinvasive T cells , and of T cells that surround but neither contact nor invade Ž . Ž the muscle fibers interstitial T cells <ref type="bibr" target="#b0">Arahata and Engel, . 1984;</ref><ref type="bibr" target="#b8">Engel and Arahata, 1984 .</ref> Combining immunohistochemical and RT-PCR techniques, we demonstrate here that the population of autoinvasive T cells is clonally restricted, whereas the interstitial T cells are clonally diverse. Together with our previous observations in PM Ž . <ref type="bibr" target="#b4">Bender et al., 1995</ref> , the present results provide a further striking example of T-cell heterogeneity and differential ( ) A. <ref type="bibr">Bender et al.r Journal of Neuroimmunology 84 1998 86-91 87</ref> TCR expression in putative autoimmune lesions of skeletal muscle.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Clinical material</head><p>IBM was diagnosed by established clinical, electrophys-Ž . iological and histological criteria <ref type="bibr" target="#b27">Mikol and Engel, 1994 .</ref> All muscle specimens harboured congophilic inclusions in some affected fibers and all specimens contained an autoaggressive inflammatory exudate. Muscle biopsy specimens were stored in liquid nitrogen for several years before the present study was conducted.</p><p>Eight IBM specimens were immunocytochemically screened for TCR expression using a panel of anti-TCR Vb mAbs. In three specimens, the autoinvasive CD8 q T cells stained with one of the available mAbs. These specimens were selected for further analysis. RNA was extracted for TCR sequence analysis. For PCR experiments, control muscle and blood samples were obtained from two patients with neurogenic atrophy. HLA-typing was performed by PCR-SSP using DNA extracted from muscle and sequence-specific commercial oligonucleotide primers Ž . Dynal, Lake Success, NY, USA . The HLA types were as follows:</p><p>patient 1, A29,33rB58,65rDR13,17rDQ2,6; patient 2, A2,68rB44,62rDR1,11rDQ3,5; patient 3, A-,3rB8,35rDR1,17rDQ2,5.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Immunohistology</head><p>Six to 10 mm cryostat sections of muscle were used for single or two-color immunofluorescence analysis with Ž mouse FITC-anti-CD8 10 mgrml; Dianova, Hamburg, . Germany and the following mouse anti-TCR mAbs: Vb 5a . mgrml; Dianova -labelled goat anti-mouse IgG. For twocolor immunofluorescence analysis, sections were first treated with unlabelled anti-TCR Vb mAb and then with goat anti-mouse IgG antibody. Next, the sections were blocked with 5% mouse serum and incubated with the FITC-labelled anti-CD8 antibody. Isotype-matched IgG at identical concentrations was substituted for primary antibodies for negative controls.</p><p>For immunohistological screening of TCR expression, immunoreactive cells were counted per high-power field at a final magnification of 250 diameters. Cell counts greater than 50 indicate 'high', between 5 and 50 'moderate', and below 5 'low' expression of a given TCR Vb element.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">RNA extraction and cDNA synthesis</head><p>Total RNA was extracted from frozen muscle with TRISOL V following the manufacturer's instructions Ž . Molecular Research Center, Cincinnati, OH . Singlestranded cDNA was synthesized from 2 mg of total RNA Ž . using oligo dT and Moloney murine leukaemia virus-de-Ž rived reverse transcriptase MBI-Fermentas, St. Leon-Rot, . Germany .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">PCR amplification of TCR Vb 3 and Vb5 sequences</head><p>Single-stranded cDNA was used as template. TCR b chains were amplified with 5 X -V gene family-specific  </p><formula xml:id="formula_0">Ž X primers Vb 3: 5 -GGAATTCTAGAGAGAAGAAG- GAGCGC-3 X ; Vb 5: 5 X -GGAATTCTCCTGGTACCAA- Ž . X . X CAG GA CCC-3 and a 3 -primer for the C b region Ž X X . Hc b 2: 5 -GGGTCGACGGTGTGGGAGATCTCTGC-3 . Ž X .</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>All primers contained artificial EcoRI 5 primers or</head><formula xml:id="formula_1">( ) B AutoinÕasiÕe T cells in muscle fibers 1 1 2 0 7 1 0 1 2 1 1 1 8 3 0 1 3 6 2 0 9 5 0 0 4 1 3 0 10 3 0 0 5 1 3 0 11 2 0 0 6 4 4 0 12 5 0 0 Ý 14 15 1 Ý 19 0 2 Ž . Six focal<label>25</label></formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ž</head><p>. each primer in buffer supplied by the manufacturer AGS . The PCR was done for 35 cycles with 1 min denaturation at 948C, 1 min annealing at 608C, 1 min extension at 728C, and a final extension for 10 min at 728C in a thermal Ž . cycler Perkin-Elmer Cetus, Norwalk, CT .</p><p>In control experiments with RNA extracted from peripheral blood cells of two patients with neurogenic atrophy, all TCR sequences obtained from cloned PCR products were different. No TCR transcripts were detected in control muscle.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">Cloning and sequencing of PCR products</head><p>PCR products were cloned into EcoRI-and BamHI-digested puc18 for sequence analysis. After transfection into</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ž</head><p>. the E.coli strain DH5a GIBCO BRL , clones containing TCR Vb inserts were identified by hybridization with a Ž</p><formula xml:id="formula_2">X T C R C b -s p e c if ic o lig o x H c b 3 : 5 - Ž . Ž .</formula><p>X . GAACAC GC TT GT TTCAGGTCCT-3 . Positive clones were sequenced by using the dideoxy chain termi-Ž nation method with the Sequenase kit U.S. Biochemical, . Cleveland, OH . The cDNA sequences were screened against Genbank and EMBL nucleotide sequence databases. The TCR sequences were designated according to the Ž . current nomenclature <ref type="bibr" target="#b2">Arden et al., 1995 .</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Screening of TCR Vb expression with anti-Vb mAbs</head><p>The purpose of the screening experiment was to identify Ž specimens in which autoinvasive T cells i.e., T cells . invading muscle fibers could be stained with one of the currently available monoclonal antibodies. Eight IBM Ž . Ž . therefore CD8 y , are present X 500 also see Table <ref type="table" target="#tab_1">1</ref> for results of the quantitative analysis . ( ) A. <ref type="bibr">Bender et al.r Journal of Neuroimmunology 84 1998 86-91 89</ref> muscle specimens were screened for TCR expression using a panel of mAbs directed against TCR-Vb 2, 3, 5. <ref type="bibr">1, 5.2, 5.3, 6.7, 8, 12.1, 13.1, 13.2, 13.3, 13.6, 16, 18, and 21.3</ref>. It should be noted that only about 50% of the human TCR Vb elements can be detected with the presently available anti-TCR Vb mAbs.</p><p>In three specimens, the autoinvasive CD8 q T cells were stained by one of the mAbs, namely anti-Vb 5.3 in patient 1, anti-Vb 5.2 in patient 2, and anti-Vb 3 in patient 3. Approximately 50 cells per high-power field stained with the indicated mAbs in these specimens. In the other Ž specimens, between 5 and 50 interstitial but not autoinva-. sive T cells per high-power field were stained with anti-Vb 5.1, 5.2, 6.7, 13.6 or 21.3.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Two-color immunofluorescence analysis of TCR expression</head><p>Next we analyzed the distribution of inflammatory T cells in patients 1, 2, and 3 using two-color fluorescence microscopy. In patient 1, two clearly distinct T cell populations were identified by differential reaction with two mAbs against the Vb 5 subfamilies Vb 5.3 and Vb 5.1 Ž . Table <ref type="table" target="#tab_1">1</ref> and Fig. <ref type="figure" target="#fig_0">1</ref> . The Vb 5.3 q T cells were mostly CD8 q and included a significant proportion of autoinvasive T cells. In contrast, the Vb 5.1 q T cells were CD8 y and mainly localized in interstitial areas.</p><p>Six focal inflammatory lesions were analyzed quantita-Ž tively for coexpression of CD8 and TCR Vb 5.3 Table <ref type="table" target="#tab_1">1</ref> . Ž and Fig. <ref type="figure" target="#fig_0">1A</ref> , or CD8 and TCR Vb 5.1 Table <ref type="table" target="#tab_1">1 and Fig.</ref> . Ž . 1B . Of all CD8 q T cells, 33.5% 84r251 were Vb 5.3 Ž . q , whereas 0.4% 1r267 were Vb 5.1 q . Conversely, Ž . Ž Ž . 95.5% 84r88 of the Vb 5.3 q but only ; 4% 1r26 of . Ž . the Vb 5.1 q T cells were CD8 q Table <ref type="table" target="#tab_1">1A</ref> . Of the T Ž . cells that invaded muscle fibers, 50% 15r30 were Vb 5.3 Ž . q Table <ref type="table" target="#tab_1">1B</ref> . Only two invasive Vb 5.1 q T cells were Ž . detected, which were CD8 y Table <ref type="table" target="#tab_1">1B</ref> .</p><p>In patient 2, nine focal inflammatory lesions were ana-Ž . lyzed. Of all CD8 q T cells, 30.4% 86r283 were Vb 5.2 Ž Ž .. q . As in patient 1, a small population ; 4% 5r143 of Ž . Vb 5.1 q T cells was observed, 84% 26r31 of which were CD8 y . Scattered cells were Vb 6.7 q or 13.6 q . Five autoinvasive T cells were detected in this specimen, two of which were Vb 5.2 q . In patient 3, approximately 40% of all CD8 q T cells and a substantial proportion of autoinvasive T cells were Vb 3 q . Unfortunately, more precise quantification was impossible in this specimen owing to poor tissue preservation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">PCR and sequence analysis of TCRs expressed in muscle</head><p>To establish whether the expanded TCR Vb q T cell populations observed in patients 1, 2 and 3 were monoclonal, oligoclonal or polyclonal, we amplified cDNA from these muscle specimens using PCR and oligonucleo- tide primers specific for the TCR Vb families identified by immunohistochemistry. The PCR products were cloned and sequenced.</p><p>Using a TCR Vb 5-specific primer that amplifies all members of the Vb 5 family, we obtained 21 TCR se-Ž . quences from muscle of patient 1 Table <ref type="table" target="#tab_3">2A</ref> . Nine of these sequences were classified as Vb 5.3 and eight of these sequences were completely identical. In striking contrast, only two of the seven Vb 5.1 sequences and none of the other Vb 5 sequences were identical. Thus, in this Ž patient the population of Vb 5.3 q T cells which includes CD8 q autoinvasive T cells as revealed by immunohisto-. chemistry was essentially monoclonal, whereas the inter-Ž . stitial noninvasive CD8 y Vb 5.1 q T cells were clonally diverse.</p><p>In patient 2, 5 of the 7 amplified Vb 5.2 sequences were identical, whereas most of the other amplified Vb 5 se-Ž . quences were different Table <ref type="table" target="#tab_3">2B</ref> . Note that some of the Ž . few autoinvasive T cells identified in this patient were Ž . Vb 5.2 q by immunohistochemistry see Section 3.2 . In patient 3, a Vb 3-specific TCR family primer was used for ( ) A. <ref type="bibr">Bender et al.r Journal of Neuroimmunology 84 1998 86-91 90</ref> PCR amplification. Eight of 14 Vb 3 sequences were iden-Ž . tical Table <ref type="table" target="#tab_3">2C</ref> .</p><p>Thus, in all three patients analyzed, the immunocytochemically identified population of autoinvasive T cells is oligoclonal or even monoclonal by TCR sequence analysis. In patient 1, a complementary population of CD8 y interstitial T cells were stained with a mAb against Vb 5.1. These Vb 5.1 q interstitial T cells were clonally diverse. Furthermore, in control experiments, the same PCR primers were used for amplification of TCR Vb sequences from Ž . blood of two control subjects see Section 2 . As expected, all TCR sequences obtained from blood were different.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p>Our results demonstrate that the autoinvasive and interstitial T cells in IBM muscle express a different TCR repertoire. Patient 1 was especially informative. Here, two different mAbs serendipitously labelled two distinct populations of T cells: a CD8 q Vb 5.3 q population of autoinvasive T cells and a CD8 y Vb 5.1 q population of noninvasive interstitial T cells. PCR and TCR sequence analysis revealed that only the autoinvasive Vb 5.3 q T cells were clonally restricted, whereas the interstitial Vb 5.1 q T cells were clonally diverse. This case, therefore, illustrates the phenotypic and functional heterogeneity of the T cell infiltrate in muscle lesions. Indeed, we have previously Ž noted this phenomenon in a case of <ref type="bibr">PM Bender et al., . 1995</ref> . Other workers have investigated the TCR repertoire Ž . in IBM immunocytochemically <ref type="bibr" target="#b24">Lindberg et al., 1994</ref> or Ž . by <ref type="bibr">PCR O'Hanlon et al., 1994;</ref><ref type="bibr" target="#b12">Fyhr et al., 1996 , but</ref>  Both techniques employed in our study, immunohistochemistry with TCR Vb family-specific mAbs and RT-PCR with Vb-family specific oligonucleotide primers, have their limitations. First, immunohistochemical analysis is constrained by the presently available panel of anti-TCR Vb mAbs that detect only about 50% of the existing TCR Vb elements. Second, PCR results are difficult to quantify and do not distinguish between pathogenetically relevant and irrelevant TCRs. To circumvent these limitations and to make optimal use of the information obtained with either technique, we combined the immunocytochemical analysis with PCR, using the same approach that enabled us to demonstrate a restricted TCR repertoire in PM <ref type="bibr">ŽPluschke et al., 1992;</ref><ref type="bibr" target="#b19">Hohlfeld et al., 1991;</ref><ref type="bibr" target="#b4">Bender et al., . 1995</ref> . Because only about 50% of the Vb specificities are recognized by the available antibodies, not all cases of IBM are amenable to analysis by the combined approach. This likely explains why the autoinvasive T cells were stained only in three of the eight screened IBM cases.</p><p>Because concomitant blood samples were unavailable from the patients whose cryopreserved muscle specimens we studied, we cannot state whether the TCRs expressed by autoinvasive T cells in muscle were also expressed by T cells circulating in blood at the time of biopsy. However, in our previous studies on PM mediated either by abor gd-T cells, we did not detect myocytotoxic T cell clones in parallel blood samples by immunofluorescence or even Ž PCR <ref type="bibr" target="#b4">Bender et al., 1995;</ref><ref type="bibr" target="#b19">Hohlfeld et al., 1991;</ref><ref type="bibr" target="#b30">Pluschke . et al., 1992</ref> . This strongly suggests that in inflammatory myopathies the autoaggressive T cells can accumulate and probably locally expand in muscle without circulating in blood in detectable amounts at the time of biopsy.</p><p>Ž . Although the identity of the target antigen s in IBM remains unknown, the known properties of the HLA class Ž I-restricted pathway of antigen presentation Germain, . Ž . Ž 1994 predict that the antigen s presented are short 8-10-. mer peptides, derived mostly from endogenously synthesized viral or self proteins. Moreover, the failure of repeated attempts to identify viral antigens or genomes in Ž IBM Leon-Monzon and <ref type="bibr">Dalakas, 1992;</ref><ref type="bibr" target="#b20">Jongen et al., 1993;</ref><ref type="bibr" target="#b10">Fox et al., 1994;</ref><ref type="bibr" target="#b22">Leff et al., 1992;</ref><ref type="bibr" target="#b28">Nishino et al., . 1989</ref> weighs in favor of an autoimmune reaction against Ž . muscle self antigen s . This, however, does not preclude triggering of the autoimmune response by a viral infection Ž . by molecular mimicry <ref type="bibr" target="#b11">Fujinami and Oldstone, 1985</ref> . The likelihood of an autoimmune mechanism in IBM is further strengthened by the clinical association with other autoim-Ž mune diseases <ref type="bibr" target="#b27">Mikol and Engel, 1994;</ref><ref type="bibr" target="#b32">Sekul and Dalakas, . 1993;</ref><ref type="bibr" target="#b6">Dalakas and Sivakumar, 1996</ref> , and by the immuno-Ž genetic association with HLA-DR3 <ref type="bibr" target="#b13">Garlepp et al., 1994;</ref><ref type="bibr" target="#b33">. Sivakumar et al., 1997 .</ref> Muscle fibers are exceptional as potential targets of cytotoxic CD8 q T cells in that they normally do not express detectable levels of HLA. In the inflammatory myopathies, however, many muscle fibers express abun-Ž . dant HLA class I but only very rarely HLA class II Ž . <ref type="bibr" target="#b21">Karpati et al., 1988;</ref><ref type="bibr" target="#b7">Emslie-Smith et al., 1989 .</ref> Because HLA expression can be enhanced in cultured myotubes by Ž stimulation with interferon-g <ref type="bibr" target="#b15">Goebels et al., 1992;</ref><ref type="bibr"></ref> . <ref type="bibr" target="#b26">Michaelis et al., 1993</ref> , at least part of the observed HLA expression may be induced by locally secreted cytokines. Cytokines likely influence not only HLA expression but also antigen processing by muscle fibers, favoring the presentation of self proteins that normally occur only in Ž . small amounts <ref type="bibr" target="#b18">Hohlfeld and Engel, 1994 .</ref> Apart from inflammatory changes, microscopic findings in IBM include rimmed vacuoles, congophilic amyloid deposits typically near or within the vacuoles and occasionally in nuclei, necrotic and regenerating fibers, small groups of atrophic fibers, and mitochondrial abnormalities <ref type="bibr">ŽAskanas et al., 1994;</ref><ref type="bibr" target="#b27">Mikol and Engel, 1994;</ref><ref type="bibr" target="#b17">Griggs et . al., 1995;</ref><ref type="bibr" target="#b5">Carpenter, 1996 .</ref> The relative significance of these alterations and their possible relation to the inflam-Ž . matory changes are presently debated <ref type="bibr" target="#b17">Griggs et al., 1995 .</ref> That nonnecrotic muscle fibers invaded by T cells are several fold more frequent than fibers displaying other Ž . pathologic alterations <ref type="bibr" target="#b31">Pruitt et al., 1996</ref> suggests that, despite refractoriness to immunotherapy, immune mechanisms play an important role in the pathogenesis of IBM. ( ) A. <ref type="bibr">Bender et al.r Journal of Neuroimmunology 84 1998 86-91 91</ref> </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Localization of CD8 and TCR Vb elements by double-fluorescence immunohistochemistry in muscle of patient 1. A Colocalization of CD8 Ž . Ž . green, FITC and Vb 5.3 red, Cy3 antigens. T cells positive for both antigens appear yellow. Arrows indicate two autoinvasive double-positive T cells. Colocalization of CD8 green, FITC and Vb 5.1 red, Cy3 antigens. A few interstitial Vb 5.1 q cells, which appear red arrows and are</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 Ž</head><label>1</label><figDesc>Quantitative immunohistochemical analysis of inflammatory T cells pa-</figDesc><table><row><cell>. tient 1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">CD8rVb 5.3</cell><cell></cell><cell></cell><cell cols="2">CD8rVb 5.1</cell><cell></cell><cell></cell></row><row><cell cols="8">Lesion no. qry qrq yrq Lesion no. qry qrq yrq</cell></row><row><cell cols="3">( ) A T cells in muscle lesion</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1</cell><cell>30</cell><cell>20</cell><cell>0</cell><cell>7</cell><cell>68</cell><cell>1</cell><cell>10</cell></row><row><cell>2</cell><cell>22</cell><cell>11</cell><cell>3</cell><cell>8</cell><cell>44</cell><cell>0</cell><cell>3</cell></row><row><cell>3</cell><cell>39</cell><cell>14</cell><cell>0</cell><cell>9</cell><cell>33</cell><cell>0</cell><cell>4</cell></row><row><cell>4</cell><cell>1 9</cell><cell>8</cell><cell>0</cell><cell>1 0</cell><cell>4 0</cell><cell>0</cell><cell>3</cell></row><row><cell>5</cell><cell>1 7</cell><cell>7</cell><cell>1</cell><cell>1 1</cell><cell>3 9</cell><cell>0</cell><cell>4</cell></row><row><cell>6</cell><cell>40</cell><cell>24</cell><cell>0</cell><cell>12</cell><cell>42</cell><cell>0</cell><cell>1</cell></row><row><cell>Ý</cell><cell>167</cell><cell>84</cell><cell>4</cell><cell>Ý</cell><cell>266</cell><cell>1</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 a</head><label>2</label><figDesc>New</figDesc><table><row><cell></cell><cell cols="3">designation Previous designation N-Db-N</cell><cell cols="2">Jb C b f</cell></row><row><cell cols="5">( ) A Sequence analysis of TCR Vb expression in IBM patient 1</cell></row><row><cell cols="2">BV5S3</cell><cell>5.3</cell><cell>PGQY</cell><cell>1.5 1</cell><cell>8r21</cell></row><row><cell cols="2">BV5S3</cell><cell>5.3</cell><cell cols="2">WGVVGAL 1.1 1</cell><cell>1r21</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>PPSGG</cell><cell>2.3 2</cell><cell>2r21</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>LTGSG</cell><cell>1.4 1</cell><cell>1r21</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>LAGLLS</cell><cell>2.1 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>MGHT</cell><cell>2.5 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>LRTGAG</cell><cell>2.7 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell cols="2">TVGGDSD 2.7 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S2</cell><cell>5.2</cell><cell>FLAPS</cell><cell>2.1 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S6A3N2T</cell><cell>5.5</cell><cell>LAAF</cell><cell>2.1 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S6A3N2T</cell><cell>5.5</cell><cell>QDSE</cell><cell>2.2 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S6A3N2T</cell><cell>5.5</cell><cell>LRTH</cell><cell>2.3 2</cell><cell>1r21</cell></row><row><cell cols="2">BV5S4A1T</cell><cell>1GRb06</cell><cell>LDDS</cell><cell>2.3 2</cell><cell>1r21</cell></row><row><cell cols="5">( ) B Sequence analysis of TCR Vb expression in IBM patient 2</cell></row><row><cell cols="2">BV5S2</cell><cell>5.2</cell><cell>QRDPL</cell><cell>2.2 2</cell><cell>5r14</cell></row><row><cell cols="3">BV5S6A3N2T 5.5</cell><cell>IETL</cell><cell>2.3 2</cell><cell>2r14</cell></row><row><cell cols="2">BV5S2</cell><cell>5.2</cell><cell>GSIK</cell><cell>1.5 1</cell><cell>1r14</cell></row><row><cell cols="2">BV5S2</cell><cell>5.2</cell><cell>VGGF</cell><cell>2.7 2</cell><cell>1r14</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>FPGGSNS</cell><cell>2.1 2</cell><cell>1r14</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell cols="2">SPGGLVL 2.2 2</cell><cell>1r14</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell cols="2">RSEGTLLR 2.7 2</cell><cell>1r14</cell></row><row><cell cols="2">BV5S1A1T</cell><cell>5.1</cell><cell>GVGGSA</cell><cell>2.7 2</cell><cell>1r14</cell></row><row><cell cols="2">BV5S6A3N2T</cell><cell>5.5</cell><cell>FGSA</cell><cell>2.1 2</cell><cell>1r14</cell></row><row><cell cols="5">( ) C Sequence analysis of TCR Vb expression in IBM patient 3</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell>LRTDA</cell><cell>1.4 1</cell><cell>8r14</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell>LRGFD</cell><cell>1.1 1</cell><cell>1r14</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell>FVG</cell><cell>1.5 1</cell><cell>1r14</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell>LRGY</cell><cell>1.5 1</cell><cell>1r14</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell>GGPAGT</cell><cell>2.1 2</cell><cell>1r14</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell cols="2">FRGWP1GS 2.1 2</cell><cell>1r14</cell></row><row><cell cols="2">BV3S1</cell><cell>3</cell><cell cols="2">NPTGQLG 2.7 2</cell><cell>1r14</cell></row><row><cell>a</cell><cell cols="5">Ž f, Frequency number of positive clones divided by total number of</cell></row><row><cell cols="4">. clones . Expanded sequences are printed in bold face.</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Acknowledgements This study was supported by the Deutsche Forschungs-Ž . gemeinschaft SFB 217, C13 , Wilhelm Sander Stiftung Ž . Ž . 94.068.1 , Max Planck Society R.H., A.B., and L.B. , and NS-6277 from NIH and a Research Grant from the Ž . MDA A.G.E. .</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies: I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="193" to="208" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies: III. Immunoelectron microscopy aspects of cell-mediated muscle fiber injury</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="112" to="125" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Human T-cell receptor variable gene segment families</title>
		<author>
			<persName><forename type="first">B</forename><surname>Arden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kabelitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Mak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="455" to="500" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Idiopathic inflammatory myopathies: Inclusion-body myositis, polymyositis and dermatomyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Neurol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="48" to="456" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">T cell receptor repertoire in polymyositis: Clonal expansion of autoaggressive CD8 q T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iglesias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dornmair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="1863" to="1868" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1105" to="1114" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Neurol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="235" to="239" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes and T-cell-mediated cytotoxicity in myopathies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Emslie-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Pathol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="224" to="231" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies: II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="209" to="216" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">The polymyositis and dermatomyositis syndromes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Q</forename><surname>Banker</surname></persName>
		</author>
		<editor>Engel, A.G., Franzini-Armstrong, C. Ž . Eds. , Myology. McGraw-Hill</editor>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="page" from="1335" to="1383" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Search for persistent enterovirus infection of muscle in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Finklestone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Swanson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol. Sci</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="70" to="76" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Amino acid homology between Ž . the encephalitogenic site of myelin basic protein MBP and virus: Mechanism for autoimmunity</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Fujinami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B A</forename><surname>Oldstone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">230</biblScope>
			<biblScope unit="page" from="1043" to="1046" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Limited T cell receptor V gene usage in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I.-M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="109" to="114" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">HLA associations with inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ollier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Exp. Immunol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Germain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="287" to="299" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Human myoblasts as antigen presenting cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="661" to="667" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Engelhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pongratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tschopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jenne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2905" to="2910" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and myopathies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Griggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Rowland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="707" to="713" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The immunobiology of muscle</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol. Today</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="269" to="274" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Polymyositis mediated by T lymphocytes that express the gd receptor</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Harper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="page" from="877" to="881" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Polymyositis and dermatomyositis: No persistence of enterovirus or encephalomyocarditis virus RNA in muscle</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J H</forename><surname>Jongen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Zoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beaumont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J G</forename><surname>Melchers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B A</forename><surname>Van De Putte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M D</forename><surname>Galama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Rheum. Dis</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="575" to="578" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Expression of immunoreactive major histocompatibility complex products in human skeletal muscles</title>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pouliot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="64" to="72" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="1192" to="1195" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="219" to="222" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2659" to="2663" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Inflammatory myopathies and systemic disorders: A review of immunopathogenetic mechanisms and clinical features</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mantegazza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bernasconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Confalioneri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cornelio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol</title>
		<imprint>
			<biblScope unit="volume">244</biblScope>
			<biblScope unit="page" from="277" to="287" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1142" to="1149" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<editor>Engel, A.G., Ž . Franzini-Armstrong, C. Eds. , Myology. Basic and Clinical. Mc-Graw-Hill</editor>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="page" from="1384" to="1398" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: The mumps virus hypothesis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Rima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="260" to="264" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The ab T-cell receptor repertoire in inclusion body myositis: Diverse patterns of gene expression by muscle-infiltrating lymphocytes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Autoimmun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="321" to="333" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Autoaggressive myocytotoxic T lymphocytes expressing an unusual gd T cell receptor</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pluschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ruegg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="1785" to="1789" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis: Counts of different types of abnormal fibers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Pruitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Showalter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="139" to="143" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: New concepts</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Sekul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin. Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="256" to="263" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Semino-Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="653" to="661" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
